[RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA - GOOD RESPONSE TO RITUXIMAB TREATMENT]
Harefuah
.
2020 May;159(5):339-342.
[Article in Hebrew]
Authors
Lital Shaham
1
,
Dikla Pivko
1
,
Yaakov Schechter
1
,
Moshe Yana
1
,
Nehama Sharon
2
Affiliations
1
Department of Pediatrics, Laniado Medical Center, Netanya, Israel.
2
Department of Pediatrics, Division of Pediatric Hematology-Oncology, Laniado Medical Center, Netanya, Israel.
PMID:
32431123
No abstract available
MeSH terms
Anemia, Hemolytic, Autoimmune* / drug therapy
Antibodies, Monoclonal* / therapeutic use
Humans
Rituximab* / therapeutic use
Treatment Outcome
Substances
Antibodies, Monoclonal
Rituximab